We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Rapid New Test Developed for MRSA

By HospiMedica staff writers
Posted on 09 Feb 2006
A new screening method for methicillin-resistant Staphylococcus aureus (MRSA) slashes the time needed to identify patients with MRSA by 75%, decreasing the time between screening and notification of results from four days to one day, according to a new study published in the January 31, 2006, online issue of Critical Care by Biomed Central (www.biomedcentral.com).

Stephan Harbarth and colleagues from the Geneva University Hospitals (Switzerland; www.hug-ge.ch) used quantitative MRSA (qMRSA), a new screening method that identifies MRSA DNA in patient swabs, to test 1,053 patients upon admission to the medical intensive care unit (ICU) and the surgical ICU in Geneva University Hospital. More...
The study ran from January 2003 to August 2005. Standard microbiologic methods were used to compare the time it took to get results of qMRSA with this method versus historical records of the time taken to get notification of test results.

The median time from ICU admission until notification of test results decreased from 87 hours to 21 hours in the surgical ICU and from 106 hours to 23 hours in the medical ICU. Infected patients immediately after MRSA detection substantially decreased MRSA infections in the medical ICU but not in the surgical ICU. In the surgical ICU, qMRSA spared 245 MRSA-negative patients a total of 1, 227 unnecessary days in isolation.




Related Links:
Geneva U. Hospitals

Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Patient Monitoring System
AlarmSense
Immobilization System
Cranial 4Pi Immobilization
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: New findings show that chemotherapy plus immunotherapy before surgery produced greater tumor destruction than immunotherapy alone in head and neck cancer patients (Image Credit: Adobe Stock)

Combination Therapy Before Surgery Drives Stronger Tumor Reduction in Head and Neck Cancer

Patients with head and neck cancer who are scheduled for surgery often face a waiting period with limited treatment, creating an opportunity to reduce viable tumor burden before the operation.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.